Castle PE - Search Results

1

Commentary on statement on human papillomavirus test utilization.

Cox JT, Moriarty AT, Castle PE. Cox JT, et al. Among authors: castle pe. Arch Pathol Lab Med. 2009 Aug;133(8):1192-4. doi: 10.5858/133.8.1192. Arch Pathol Lab Med. 2009. PMID: 19653706 Free article. No abstract available.

2

Human papillomavirus: epidemiology and public health.

Schiffman M, Castle PE. Schiffman M, et al. Among authors: castle pe. Arch Pathol Lab Med. 2003 Aug;127(8):930-4. doi: 10.5858/2003-127-930-HPEAPH. Arch Pathol Lab Med. 2003. PMID: 12873163 Free article.

3

Performance of direct visual inspection of the cervix with acetic acid and magnification in a previously screened population.

Rodríguez AC, Morera LA, Bratti C, Herrero R, Cox JT, Morales J, Alfaro M, Hutchinson M, Castle PE, Hildesheim A, Schiffman M. Rodríguez AC, et al. Among authors: castle pe. J Low Genit Tract Dis. 2004 Apr;8(2):132-8. doi: 10.1097/00128360-200404000-00009. J Low Genit Tract Dis. 2004. PMID: 15874851

4

Chapter 7: Achievements and limitations of cervical cytology screening.

Kitchener HC, Castle PE, Cox JT. Kitchener HC, et al. Among authors: castle pe. Vaccine. 2006 Aug 31;24 Suppl 3:S3/63-70. doi: 10.1016/j.vaccine.2006.05.113. Vaccine. 2006. PMID: 16950019 Review.

5

American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.

Saslow D, Castle PE, Cox JT, Davey DD, Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki AB, Noller KL, Wheeler CM, Ades T, Andrews KS, Doroshenk MK, Kahn KG, Schmidt C, Shafey O, Smith RA, Partridge EE; Gynecologic Cancer Advisory Group; Garcia F. Saslow D, et al. Among authors: castle pe. CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28. doi: 10.3322/canjclin.57.1.7. CA Cancer J Clin. 2007. PMID: 17237032 Free article. Review.

6

An analysis of high-risk human papillomavirus DNA-negative cervical precancers in the ASCUS-LSIL Triage Study (ALTS).

Castle PE, Cox JT, Jeronimo J, Solomon D, Wheeler CM, Gravitt PE, Schiffman M. Castle PE, et al. Obstet Gynecol. 2008 Apr;111(4):847-56. doi: 10.1097/AOG.0b013e318168460b. Obstet Gynecol. 2008. PMID: 18378743

7

Factors influencing histologic confirmation of high-grade squamous intraepithelial lesion cytology.

Castle PE, Cox JT, Schiffman M, Wheeler CM, Solomon D. Castle PE, et al. Obstet Gynecol. 2008 Sep;112(3):637-45. doi: 10.1097/AOG.0b013e3181834637. Obstet Gynecol. 2008. PMID: 18757663 Free PMC article. Clinical Trial.

8

Commentary on: Statement on HPV DNA test utilization.

Cox JT, Moriarty AT, Castle PE. Cox JT, et al. Among authors: castle pe. Diagn Cytopathol. 2009 Jul;37(7):471-4. doi: 10.1002/dc.21098. Diagn Cytopathol. 2009. PMID: 19459174 No abstract available.

9

Commentary on: Statement on HPV DNA test utilization.

Cox JT, Moriarty AT, Castle PE. Cox JT, et al. Among authors: castle pe. J Low Genit Tract Dis. 2009 Jul;13(3):131-4. doi: 10.1097/LGT.0b013e3181a4e4a8. J Low Genit Tract Dis. 2009. PMID: 19550208 No abstract available.

10

Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.

Moore G, Fetterman B, Cox JT, Poitras N, Lorey T, Kinney W, Castle PE. Moore G, et al. Among authors: castle pe. J Low Genit Tract Dis. 2010 Apr;14(2):97-102. doi: 10.1097/LGT.0b013e3181b8b024. J Low Genit Tract Dis. 2010. PMID: 20354416 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

515 results

Search Page